FDA staff raises eye damage concerns for GSK's blood cancer drug
ReutersJul 15, 2025 12:30 PM
July 15 (Reuters) - The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's GSK.L blood cancer drug, when used in combination with other treatments, may cause eye damage in patients.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Is the Market No Longer ‘Buying Asia’? Why Asian Stocks Face Selloff Amid US-Iran Conflict While US Stocks Become a Safe Haven?
Has the "Sell US, Buy Asia" trade, once prevalent at the beginning of the year, now become obsolete? Will the U.S.-Iran conflict fundamentally reverse the robust 2026 rally in emerging markets?TradingKey
an hour ago
Is the Market No Longer ‘Buying Asia’? Why Asian Stocks Face Selloff Amid US-Iran Conflict While US Stocks Become a Safe Haven?
Has the "Sell US, Buy Asia" trade, once prevalent at the beginning of the year, now become obsolete? Will the U.S.-Iran conflict fundamentally reverse the robust 2026 rally in emerging markets?TradingKey
an hour ago
Investing in GameStop 2026: Holding Company Transformation or Just More Hype?
Although GameStop still has physical stores, it is predominantly looking to buy/build out new businesses that can expand more quickly than it is shrinking traditional video game retail stores, which are going to disappear.TradingKey
12 hours ago
It’s Not Gold Soaring; It’s Paper Money Shrinking: Measuring Gold with Five Real-World Yardsticks
TradingKey – Want to know where gold’s true level really is? This article measures it against stocks, the US dollar, housing, oil and even burgers to show where its price really stands today.TradingKey
19 hours ago
US-Iran Conflict Ignites, Global Arms Race Heats Up, Will Defense Stocks See a New Round of Gains?
TradingKey - On February 28 local time, the United States and Israel launched joint large-scale airstrikes against Iran, targeting its nuclear facilities, missile industry, and naval forces. This marks another sharp escalation in the conflict following the US military strikes on Iranian nuclear facilities in June last year. The military operation not only exacerbates already strained geopolitical tensions but has also sent shockwaves through global capital markets, which is expected to further boost defense stocks.TradingKey
Mon, Mar 2
